T3 Mycin

T3 Mycin



Hoe Pharma


Zuellig Pharma


Taisho Pharmaceutical
Concise Prescribing Info
Clindamycin phosphate
Dosage/Direction for Use
Hypersensitivity to lincomycin, propylene glycol & clindamycin. History of regional enteritis, ulcerative colitis or antibiotic-related colitis.
Special Precautions
Avoid contact w/ eyes or mucous membranes. Discontinue if significant diarrhoea occurs. Pregnancy & lactation.
Adverse Reactions
Contact dermatitis, local irritation (eg, erythema, peeling & burning), dryness, oily skin, gm-ve folliculitis. Bloody diarrhoea, diarrhoea, colitis (including pseudomembranous colitis) & GI disturbances.
Drug Interactions
May enhance action of neuromuscular blockers. Avoid concurrent administration w/ erythromycin.
ATC Classification
D10AF01 - clindamycin ; Belongs to the class of topical antiinfective preparations used in the treatment of acne.
Additional Information
Exemptions granted for limited sale and supply without prescription (with effect from 31 March 2016):
As a topical preparation not exceeding 1%
Indication: Treatment of acne vulgaris
Maximum daily dose: Apply to the affected areas twice daily*
*Once daily for fixed combination products containing topical clindamycin not exceeding 1% and benzoyl peroxide
Maximum supply: 30 g for gel; 30 mL for topical solution/lotion
Minimum age: 12 years
T3 Mycin topical gel 1%
25 g x 1's
T3 Mycin lotion 1%
30 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in